Analysts remain cautious about Equillium, Inc. despite bette...
Analysts remain cautious about Equillium, Inc. despite better earnings and revenue projections. The 35% reduction in price target signifies this. With anticipated 11% annual revenue decline by end of 2023, skepticism about Equillium's future performance compared to recent growth and industry peers is evident.
Equillium, Inc. (NASDAQ:EQ) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment